Legal status in the United States
Is Low-Dose Naltrexone legal?
Read at FDA, DEA and WADAPublished by PepVault
Low-Dose Naltrexone is FDA-approved (Revia and Naltrexone hydrochloride (generic), first in 1984), is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 19, 2026.
Low-Dose Naltrexone at a glance
| Check | Status, read Nov 19, 2026 |
|---|---|
| FDA approval | Approved (Revia, 1984) |
| Compounding | Not checked yet |
| DEA schedule | Not controlled |
| Sport (WADA) | Not named on the list |
FDA approval
Naltrexone hydrochloride is FDA-approved, first as Revia tablets in 1984, at 50 mg for alcohol dependence and to block the effects of opioids. Drugs@FDA lists that Revia application as discontinued; generic naltrexone tablets are sold today under later applications. No low-dose product is approved: the 1 to 6 mg doses are off-label, usually made up by a compounding pharmacy.
Revia (tablet)
Approved for alcohol dependence; blocking the effects of opioids. NDA 018932, first approved November 20, 1984; discontinued.
- Drugs@FDA: Revia, application 018932, U.S. Food and Drug Administration. Read .
- Naltrexone hydrochloride tablets prescribing information on DailyMed, National Library of Medicine (DailyMed). Read .
Naltrexone hydrochloride (generic) (tablet)
Approved for alcohol dependence; blocking the effects of opioids. ANDA 090356, first approved February 24, 2012.
- Drugs@FDA: Naltrexone hydrochloride, application 090356, U.S. Food and Drug Administration. Read .
- Naltrexone hydrochloride tablets prescribing information on DailyMed, National Library of Medicine (DailyMed). Read .
- Drugs@FDA: Revia, application 018932, U.S. Food and Drug Administration. Read .
- Drugs@FDA data (openFDA): applications listing “NALTREXONE HYDROCHLORIDE” as an active ingredient, U.S. Food and Drug Administration. Read .

Compounding
Not checked yet. We could not settle this at its primary source on November 19, 2026, so the page leaves it out rather than guess.
DEA schedule
It is not a federally controlled substance: the DEA’s Schedule II names it only to exclude it, among the opiate derivatives (21 CFR 1308.12), and it is not on the DEA’s alphabetical list of controlled substances.
The source: “naloxegol, naloxone, 6β-naltrexol, naltrexone, and samidorphan”
- 21 CFR Part 1308, Schedules of Controlled Substances (eCFR, up to date as of November 16, 2026), Electronic Code of Federal Regulations. Read .
- Controlled Substances, Alphabetical Order (dated November 17, 2026), Drug Enforcement Administration, Diversion Control Division. Read .
Sport (WADA)
WADA’s 2026 Prohibited List doesn’t name naltrexone, and it is an approved drug, so S0, the class for unapproved substances, doesn’t reach it.
- World Anti-Doping Code International Standard, Prohibited List 2026 (in effect from January 1, 2026), World Anti-Doping Agency. Read .
What this means and doesn’t
This page reports what the agencies’ own pages said about Low-Dose Naltrexone in the United States when we read them on November 19, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.
It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.
Questions
Is Low-Dose Naltrexone FDA approved?
Naltrexone hydrochloride is FDA-approved, first as Revia tablets in 1984, at 50 mg for alcohol dependence and to block the effects of opioids. Drugs@FDA lists that Revia application as discontinued; generic naltrexone tablets are sold today under later applications. No low-dose product is approved: the 1 to 6 mg doses are off-label, usually made up by a compounding pharmacy.
Is Low-Dose Naltrexone a controlled substance?
It is not a federally controlled substance: the DEA’s Schedule II names it only to exclude it, among the opiate derivatives (21 CFR 1308.12), and it is not on the DEA’s alphabetical list of controlled substances.
Is Low-Dose Naltrexone banned in sport?
WADA’s 2026 Prohibited List doesn’t name naltrexone, and it is an approved drug, so S0, the class for unapproved substances, doesn’t reach it.